JHX Investors Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire November 14, 2025 LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against James Hardie Industries plc (“James Hardie” or […]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet Holdings, Inc.") (NYSE:ZBH) concerning possible violations of federal securities laws. Zimmer Biomet issued a press release on November 5, 2025, announcing its financial results for the

— Operating revenue was $80.5 billion, a 1.2 percent increase, due largely to growth in USPS Ground Advantage and strategic price increases — Net loss decreased $542 million compared to prior year while controllable loss increased by $900 million, reflecting lower than expected revenues from our package business — Transportation expense reductions of $422 million

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Varonis Systems, Inc. ("Varonis Systems, Inc.") (NASDAQ:VRNS) concerning possible violations of federal securities laws. On October 28, 2025, Varonis reported third quarter fiscal 2025 revenue below estimates on the back of weaker

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alkami Technology, Inc. ("Alkami Technology, Inc.") (NASDAQ:ALKT) concerning possible violations of federal securities laws. Alkami issued a press release on October 30, 2025, reporting its financial results for the third quarter of

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi

On November 20, London will become the global spotlight for cell and gene therapy (CGT) as a Nobel Laureate, scientific leaders, biotech innovators, and top investors gather to chart the future of one of the fastest-growing fields in emerging medicine. With the event just around the corner, this is the last call for registration. Complimentary

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion

FORT LAUDERDALE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — REIGN BAR, the innovative vapor technology brand, made a significant impact at the CHAMPS trade show (Booth 3009) running from November 11-13 in Fort Lauderdale, captivating industry leaders by showcasing its three groundbreaking products: the newly launched transparent e-Hookah AMBER 40K, the industry-first magnetic flavor-mixing system